Aggamin Pharmaceuticals LLC

Brookline, MA

UEI
E21PRNABGN38
CAGE
5VEF6
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Other
SAM.gov registration date
Physical address
117 Woodcliff Rd, Chestnut Hill, MA 02467, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of a novel biologic to treat preeclampsia R44HD082657 National Institute of Child Health and Human Development (NIH) $1,361,855
Development of a novel biologic to treat preeclampsia R43HD082657 National Institutes of Health $218,009
Novel EX-vivo immunoadsorption therapy to treat preeclampsia R43HD075571 National Institutes of Health $245,087
Novel EX-vivo immunoadsorption therapy to treat preeclampsia R44HD075571 National Institutes of Health $1,243,090

Quick answers

Is Aggamin Pharmaceuticals LLC registered in SAM.gov?

Yes. Aggamin Pharmaceuticals LLC's SAM.gov registration is active through March 18, 2027.

What is Aggamin Pharmaceuticals LLC's most recent federal award?

Aggamin Pharmaceuticals LLC's most recent federal grant award is Development of a novel biologic to treat preeclampsia (R44HD082657), from National Institute of Child Health and Human Development (NIH), on September 25, 2014.

On GovTribe

See Aggamin Pharmaceuticals LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login